theophylline anhydrous 200 mg / 1 Capsule 100 Capsule, Extended Release (Theo-24)
Comprehensive product details for sourcing and verification.
| NDC 11 | 52244-0200-10 |
|---|---|
| Product NDC | 52244-0200 |
| Generic Drug Name | theophylline anhydrous |
| Brand Name | Theo-24 |
| Manufacturer | ENDO USA, Inc. |
| Strength | 200 mg / 1 |
| Dosage Form | Capsule |
| Drug Type | Oral |
| Package Quantity | 100 Capsule, Extended Release |
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52244-200-10) |
| Active Ingredients | Theophylline Anhydrous |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
theophylline anhydrous 200 mg / 1 Capsule is tracked under NDC 52244-0200-10 and rolls up into product family 52244-0200. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 100 Capsule, Extended Release.
- Manufacturer: ENDO USA, Inc..
- Dosage form: Capsule.
- Family size: 1 active presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
Public sources show a current shortage summary for theophylline 24-hour products plus an official state recall notice for a related theophylline extended-release tablet presentation.
Drug Shortage Index family
View Theophylline anhydrous in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Theophylline anhydrous.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
theophylline anhydrous 200 mg / 1 Capsule 100 Capsule, Extended Release (Theo-24), NDC 52244-0200-10, is a ENDO USA, Inc. 200 mg / 1 capsule presentation packaged as 100 Capsule, Extended Release. Current public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 52244-0200-10.
- Digits-only NDC 11: 52244020010.
- Possible 10-digit display format: 52244-200-10 (5224420010).
Helpful product links
- Search by brand name: Theo-24.
- Exact NDC 11: 52244-0200-10.
- Product family NDC: 52244-0200.
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.